These benefits, together with a former report demonstrating that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,two help the principle of focusing on ACKR3 as a novel strategy to modulate the opioid technique, which could open new therapeutic avenues for opioid-related disorders. A analysis review released in https://wendelll998dvd6.wikilima.com/user